Page last updated: 2024-10-24

'de novo' post-translational protein folding

Definition

Target type: biologicalprocess

The process of assisting in the correct noncovalent folding of newly formed polypeptides or folding intermediates of polypeptides that have exited the ribosome and/or have been stabilized and transferred by other chaperone proteins. This process could involve several cycles of ATP hydrolysis. [GOC:rb]

De novo protein folding is a fundamental biological process that involves the spontaneous acquisition of a functional three-dimensional structure by a polypeptide chain. This process occurs after translation and is essential for protein function. Here's a detailed breakdown:

1. **Unfolding:** Newly synthesized polypeptide chains emerge from ribosomes in an extended, unstructured state. This initial state is often referred to as a "random coil," lacking a defined three-dimensional structure.

2. **Initial Interactions:** As the polypeptide chain emerges, weak non-covalent interactions begin to form between amino acid residues. These interactions include hydrogen bonds, hydrophobic interactions, electrostatic interactions, and van der Waals forces.

3. **Folding Pathway:** The polypeptide chain explores a vast conformational space, sampling various conformations through random fluctuations. These fluctuations are driven by thermal energy and influenced by the interactions between amino acid residues. The folding process is not a linear pathway, but rather a complex landscape with multiple possible routes.

4. **Folding Nucleus:** Specific amino acid sequences within the polypeptide chain may have a higher propensity to interact, forming stable, local structures known as folding nuclei. These nuclei act as starting points for the folding process.

5. **Folding Intermediate:** As the folding nucleus forms, the polypeptide chain begins to fold around it, creating a partially folded intermediate. These intermediates may be metastable, meaning they are relatively stable but not yet fully folded.

6. **Chaperones:** Cellular chaperone proteins play a critical role in assisting the folding process. They prevent misfolding and aggregation by binding to partially folded polypeptide chains, providing a controlled environment for folding.

7. **Final Structure:** Through a series of conformational changes and interactions, the polypeptide chain eventually reaches its final, native three-dimensional structure. The native state is characterized by a specific arrangement of amino acid residues, creating a functional protein with a defined shape.

8. **Folding Stability:** The final structure is thermodynamically stable, meaning it represents the lowest energy state for the polypeptide chain. This stability is maintained by the balance of non-covalent interactions and the formation of a compact, functional structure.

9. **Misfolding and Aggregation:** Sometimes, polypeptide chains can misfold, leading to the formation of non-functional aggregates. These aggregates can be harmful to cells, contributing to diseases like Alzheimer's and Parkinson's.

In summary, de novo protein folding is a complex and highly regulated process that involves a series of interactions, conformational changes, and the assistance of chaperone proteins. The process is essential for the production of functional proteins, which are critical for all cellular processes.
'"

Proteins (1)

ProteinDefinitionTaxonomy
Ectonucleoside triphosphate diphosphohydrolase 5A nucleoside diphosphate phosphatase ENTPD5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O75356]Homo sapiens (human)

Compounds (1)

CompoundDefinitionClassesRoles
chromazonarol